Institut Claudius Regaud
Clinical trials sponsored by Institut Claudius Regaud, explained in plain language.
-
New radiation technique tested for aggressive brain cancer
Disease control TerminatedThis study tested a new way to deliver radiation for glioblastoma, a fast-growing brain tumor. It compared standard 3D radiation to a more precise method guided by special MRI scans. The goal was to see if the newer approach could help patients live longer. The trial included 180…
Phase: PHASE3 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New study tests cancer drug in frail seniors
Knowledge-focused TerminatedThis study tested the safety of the cancer drug pazopanib in frail elderly patients (75 and older) with metastatic solid tumors. Researchers aimed to find the highest safe dose by monitoring side effects during the first month of treatment. The study was terminated early after en…
Phase: PHASE1 • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated May 17, 2026 00:44 UTC